CANDIA, N.H., June 15, 2004 (PRIMEZONE) -- Liska Biometry, Inc. (OTCBB:LSKA), a biometrics solutions provider, announced today it has filed its preliminary proxy statement with the Securities and Exchange Commission (SEC). The definitive proxy statement will be mailed to shareholders of record as of May 24, 2004, in anticipation of the Company's July 9, 2004 Annual General Meeting of the shareholders.
At the Annual General Meeting, shareholders will be asked:
1. To elect six (6) Directors to serve for the terms of office specified in the accompanying proxy statement and until their successors are duly elected and qualified;
2. To ratify the appointment of Stark, Winter, Schenkein and Co., LLP as independent certified public accountants for Liska for the year ending December 31, 2004; and
3. To consider and act upon a proposal to approve the Company's 2004 Stock Option Plan
4. To transact such other business as may properly come before the meeting and any adjournment thereof.
Lam Ko Chau, Chairman and Chief Executive Officer of Liska Biometry, Inc. said, "Our four independent director nominees: Mr. G. Bryan Thomas, Dr. Javaid I. Sheikh, Mr. Gary A. Gaulding and General Jean E. Boyle, have considerable experience and are fully committed to actively assisting Liska ensure its long-term success.
For more information on Liska's proxy statement please refer to www.sec.gov
Liska Biometry Safe Harbor Statement
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Liska Biometry, see "Risk Factors" in the Company's Annual Report on Form 10- KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
For additional information contact:
Liska Biometry, Inc. Christopher J. LeClerc, Chief Operating Officer 603-540-0828 investors@liskabiometry.com Web site: http://www.liskabiometry.com